Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation

Matti Shem Tov, Chief Executive Officer, Clarivate

“This is an important milestone in Clarivate's transformation journey.”

Matti Shem Tov, Chief Executive Officer, Clarivate

“The successful completion of this transaction further advances our Value Creation Plan by sharpening our focus, simplifying our portfolio, and strengthening our financial profile.”

Matti Shem Tov, Chief Executive Officer, Clarivate

“We are now positioned as a more focused company centered on two market-leading segments with attractive recurring revenue characteristics, deep customer relationships, and significant opportunities to leverage AI-driven innovation.”

Matti Shem Tov, Chief Executive Officer, Clarivate

“I want to thank our Life Sciences & Healthcare colleagues for their many contributions to Clarivate and wish them continued success as part of Altaris,”

Matti Shem Tov, Chief Executive Officer, Clarivate

“We also thank our customers for their continued trust and partnership throughout this process.”

Michael Easton, Chief Financial Officer, Clarivate

“The completion of this transaction marks another meaningful step in executing our strategy.”

Michael Easton, Chief Financial Officer, Clarivate

“Our streamlined business model and stronger balance sheet position us well to invest in innovation, support our customers, and drive sustainable growth and shareholder value.”